152 related articles for article (PubMed ID: 12126893)
1. The cost of not implementing routine neonates immunization programmes in HBsAg high prevalence countries.
Chauvin P; Ekra D; Plotkin SA
Vaccine; 2002 Jul; 20(23-24):2848-50. PubMed ID: 12126893
[No Abstract] [Full Text] [Related]
2. Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatment.
Chen SC; Toy M; Yeh JM; Wang JD; Resch S
Pediatrics; 2013 Apr; 131(4):e1135-43. PubMed ID: 23530168
[TBL] [Abstract][Full Text] [Related]
3. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
4. Universal neonatal immunization for Hepatitis B.
Thies N
J Paediatr Child Health; 2002 Apr; 38(2):211; author reply 211-2. PubMed ID: 12031012
[No Abstract] [Full Text] [Related]
5. Survey of Impediments to Prevention of Mother-to-infant Transmission of Hepatitis B Virus by International Societies.
Chang MH; Fischler B; Blauvelt B; Ciocca M; Dhawan A; Ekong U; Ni YH; Porta G; Sibal A; DAgostino D; Wirth S; Morhan N; Schwarz KB
J Pediatr Gastroenterol Nutr; 2019 Dec; 69(6):648-654. PubMed ID: 31503215
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the compliance with the protocol for preventing perinatal hepatitis B infection in Italy.
Spada E; Tosti ME; Zuccaro O; Stroffolini T; Mele A;
J Infect; 2011 Feb; 62(2):165-71. PubMed ID: 21129400
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998.
van Steenbergen JE; Leentvaar-Kuijpers A; Baayen D; Dukers HT; van Doornum GJ; van den Hoek JA; Coutinho RA
Vaccine; 2001 Oct; 20(1-2):7-11. PubMed ID: 11567738
[TBL] [Abstract][Full Text] [Related]
8. Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas.
Ropero Álvarez AM; Pérez-Vilar S; Pacis-Tirso C; Contreras M; El Omeiri N; Ruiz-Matus C; Velandia-González M
BMC Public Health; 2017 Apr; 17(1):325. PubMed ID: 28415981
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus infection and pregnancy.
Mishra K; Cherian T
Indian Pediatr; 1999 Nov; 36(11):1175-6. PubMed ID: 10745350
[No Abstract] [Full Text] [Related]
10. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
[TBL] [Abstract][Full Text] [Related]
11. [Hepatitis B surface antigen prevalence among pregnant women. Implication for perinatal transmission].
Césa V; Choulot JJ
Arch Pediatr; 2006 Oct; 13(10):1348. PubMed ID: 16919923
[No Abstract] [Full Text] [Related]
12. [Cross-sectorial audit of hepatitis B screening of pregnant women and vaccination of newborns born to HBsAg-positive mothers in the county of Copenhagen].
de Lony S; Lando AV; Hertel J; Perrild BD; Prahl P
Ugeskr Laeger; 2004 Sep; 166(38):3300-2. PubMed ID: 15496007
[No Abstract] [Full Text] [Related]
13. Determining the point of indifference--where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise.
Varghese RM; Abraham J; James J; Puliyel JM
Indian J Gastroenterol; 2004; 23(4):154-6. PubMed ID: 15333982
[No Abstract] [Full Text] [Related]
14. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
[TBL] [Abstract][Full Text] [Related]
15. Maternal-neonatal transmission of hepatitis B virus. Epidemiology and prevention.
Zanetti AR
Ann Ist Super Sanita; 1987; 24(2):277-84. PubMed ID: 2969205
[No Abstract] [Full Text] [Related]
16. Postvaccination serologic testing results for infants aged ≤24 months exposed to hepatitis B virus at birth: United States, 2008-2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Sep; 61():768-71. PubMed ID: 23013723
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
18. Controlling perinatally acquired hepatitis B.
Abass F; Thomas RD; Rajkumar A; Gupta N; Puliyel JM
Indian J Pediatr; 2001 Apr; 68(4):365. PubMed ID: 11370450
[No Abstract] [Full Text] [Related]
19. Why should Australia adopt universal infant hepatitis B vaccination?
Thompson SC; Oman K
Aust N Z J Public Health; 1996 Aug; 20(4):436-9. PubMed ID: 8908772
[No Abstract] [Full Text] [Related]
20. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
